CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Mayne Pharma Group Limited Company Snapshot
Mayne Pharma Group Limited operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Mayne Pharma Group Limited with three other pharmaceutical manufacturers in Australasia: Probiotec Limited (2018 sales of 75.72 million Australian Dollars [US$54.67 million] ), Acrux Ltd (3.43 million Australian Dollars [US$2.48 million] of which 100% was Pharmaceutical Research and Development), and AFT Pharmaceuticals Ltd which is based in New Zealand (80.07 million New Zealand Dollars [US$54.18 million] of which 100% was Pharmaceutical).

Sales Analysis. During the year ended June of 2018, sales at Mayne Pharma Group Limited were A$530.31 million (US$382.90 million). This is a decrease of 7.4% versus 2017, when the company's sales were A$572.60 million. Contributing to the drop in overall sales was the 27.8% decline in Specialty Brands, from A$61.86 million to A$44.68 million. There were also decreases in sales in Generic Products (down 7.9% to A$385.70 million) . However, these declines were partially offset by the increase in sales of Metrics Contract Services (Mcs) (up 9.1% to A$63.08 million) and Mayne Pharma International (Mpi) (up 7.5% to A$36.84 million) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Mayne Pharma Group Limited
  Stock Performance Chart for Mayne Pharma Group Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (11/9/2018): 1.08
(Figures in Australian Dollars)
1 Week 0.0%   13 Weeks -7.7%  
4 Weeks 16.1%   52 Weeks 72.8%  
 
Mayne Pharma Group Limited Key Data:
  Ticker: MYX Country: Australia
  Exchanges: FRA Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 530,313,000
(Year Ending Jan 2019).
Employees: 750
  Currency: Australian Dollars Market Cap: 1,689,899,931
  Fiscal Yr Ends: June Shares Outstanding: 1,564,722,158
  Share Type: Units Closely Held Shares: 206,624,789
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.